Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10310401 | 0.66 | MAPT (0.35) | ALDH1A1 | |
| SCHEMBL15329364 | 0.59 | SMN1; SMN2 (0.41) | ALDH1A1 | |
| SCHEMBL10310423 | 0.58 | — | — | |
| SCHEMBL9163070 | 0.56 | ALDH1A1 (0.45) | ALDH1A1 | |
| SCHEMBL12467963 | 0.55 | — | — | |
| SCHEMBL10310470 | 0.53 | — | — | |
| SCHEMBL19953980 | 0.51 | — | — | |
| SCHEMBL4747481 | 0.51 | TSHR (0.32) | — | |
| SCHEMBL18217972 | 0.49 | ALDH1A1 (0.36) | ALDH1A1 | |
| SCHEMBL24415299 | 0.49 | MAPT (0.93) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2805938-A1 | Bi- or tricyclic sterically hindered alkoxyamines and process for their preparation | BASF SE (DE) | 2014-11-26 | — | — | EP | disclosed |
| US-8809533-B2 | Bi- or tricyclic sterically hindered alkoxyamines and process for their preparation | BASF SE (DE) | 2014-08-19 | — | — | US | disclosed |
| US-8809533-B2 | Bi- or tricyclic sterically hindered alkoxyamines and process for their preparation | BASF SE (DE) | 2014-08-19 | — | — | US | disclosed |
| EP-2464628-B1 | BI - OR TRICYCLIC STERICALLY HINDERED ALKOXYAMINES AND PROCESS FOR THEIR PREPARATION | BASF SE (DE) | 2014-07-23 | — | — | EP | disclosed |
| US-20140039100-A1 | BI - OR TRICYCLIC STERICALLY HINDERED ALKOXYAMINES AND PROCESS FOR THEIR PREPARATION | BASF SE (DE) | 2014-02-06 | — | — | US | disclosed |
| US-20140039100-A1 | BI - OR TRICYCLIC STERICALLY HINDERED ALKOXYAMINES AND PROCESS FOR THEIR PREPARATION | BASF SE (DE) | 2014-02-06 | — | — | US | disclosed |
| US-20120178829-A1 | BI - OR TRICYCLIC STERICALLY HINDERED ALKOXYAMINES AND PROCESS FOR THEIR PREPARATION | BASF SE (DE) | 2012-07-12 | — | — | US | disclosed |
| US-20120178829-A1 | BI - OR TRICYCLIC STERICALLY HINDERED ALKOXYAMINES AND PROCESS FOR THEIR PREPARATION | BASF SE (DE) | 2012-07-12 | — | — | US | disclosed |
| WO-2011018384-A1 | BI - OR TRICYCLIC STERICALLY HINDERED ALKOXYAMINES AND PROCESS FOR THEIR PREPARATION | BASF SE (DE) | 2011-02-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120178829-A1 | BI - OR TRICYCLIC STERICALLY HINDERED ALKOXYAMINES AND PROCESS FOR THEIR PREPARATION | CAT, SCO2, GPX4 | ALDH1A1 674/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.